10x Genomics (TXG) Income towards Parent Company (2018 - 2025)
Historic Income towards Parent Company for 10x Genomics (TXG) over the last 8 years, with Q4 2025 value amounting to -$16.3 million.
- 10x Genomics' Income towards Parent Company rose 6685.16% to -$16.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$43.5 million, marking a year-over-year increase of 7615.69%. This contributed to the annual value of -$43.5 million for FY2025, which is 7615.69% up from last year.
- According to the latest figures from Q4 2025, 10x Genomics' Income towards Parent Company is -$16.3 million, which was up 6685.16% from -$27.5 million recorded in Q3 2025.
- Over the past 5 years, 10x Genomics' Income towards Parent Company peaked at $34.5 million during Q2 2025, and registered a low of -$93.0 million during Q3 2023.
- For the 5-year period, 10x Genomics' Income towards Parent Company averaged around -$35.3 million, with its median value being -$36.8 million (2024).
- Per our database at Business Quant, 10x Genomics' Income towards Parent Company plummeted by 48322.48% in 2022 and then surged by 19113.65% in 2025.
- Quarter analysis of 5 years shows 10x Genomics' Income towards Parent Company stood at -$18.4 million in 2021, then increased by 6.69% to -$17.2 million in 2022, then plummeted by 184.36% to -$49.0 million in 2023, then dropped by 0.16% to -$49.0 million in 2024, then soared by 66.85% to -$16.3 million in 2025.
- Its last three reported values are -$16.3 million in Q4 2025, -$27.5 million for Q3 2025, and $34.5 million during Q2 2025.